The link between gut microbiome and chronic illness is well documented; the evidence that repairing the gut changes the course of those illnesses is emerging. Patients with myalgic encephalomyelitis have reduced bacterial diversity and signs of microbial translocation into the blood compared with healthy controls (Giloteaux et al., Microbiome, 2016). In COVID-19, the composition of the gut microbiota tracked disease severity and inflammatory markers, and the dysbiosis persisted for a month after the infection resolved, which the authors suggested could contribute to persistent symptoms (Yeoh et al., Gut, 2021). Repeated antibiotic courses shift the gut community within days and recovery is often incomplete, with the community settling in an altered state (Dethlefsen et al., Proc Natl Acad Sci U S A, 2011). On the treatment side, close adherence to a plant-rich Mediterranean diet is associated with higher short-chain fatty acid production and fiber-degrading species (De Filippis et al., Gut, 2016), which is why diet is the first and last step of the protocol.
What the evidence does not show: no trial has demonstrated that a staged gut-restoration protocol improves fatigue, cognition or infection outcomes in these conditions, so the hospital judges each plan by the markers it repeats, not by the literature alone.